Last reviewed · How we verify
Reserpilin (reserpiline)
Reserpilin (generic name: reserpiline) is a drug. It is currently in unknown development for Hypertensive disorder.
Reserpine works by depleting catecholamines and serotonin in the brain, leading to a decrease in sympathetic nervous system activity.
Reserpine is a small molecule medication with the synonyms including Reserpilic acid dimethylaminoethyl ester dihydrochloride. It is also known by other names such as Paratensiol and Resporisan.
At a glance
| Generic name | reserpiline |
|---|---|
| Therapeutic area | Cardiovascular |
| Phase | unknown |
Mechanism of action
Imagine your brain's 'fight or flight' response is like a fire alarm that gets triggered when you're stressed or excited. Reserpine essentially silences this alarm by removing the chemicals that make it go off, which can help lower blood pressure and reduce anxiety.
Approved indications
- Hypertensive disorder
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Reserpilin CI brief — competitive landscape report
- Reserpilin updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about Reserpilin
What is Reserpilin?
How does Reserpilin work?
What is Reserpilin used for?
What is the generic name of Reserpilin?
What development phase is Reserpilin in?
Related
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Cardiovascular
- Indication: Drugs for Hypertensive disorder
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing